Gelatin thrombin granules for hemostasis in a severe traumatic liver and spleen rupture model in swine

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue 2, 2008, Pages 456-461

  Leixnering, Martin ^a,b   Reichetseder, Jürgen ^b   Schultz, Arthur ^a   Figl, Markus ^a   Wassermann, Esther ^a   Thurnher, Martin ^a   Redl, Heinz ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Unfallkrankenhaus Lorenz Bohler   (Austria)

Author keywords

Gelatin thrombin; Hemorrhage; Hemostasis; Liver and spleen rupture; Shock

Indexed keywords

FLOSEAL; GELATIN; HEMOSTATIC AGENT; THROMBIN; FLOSEAL MATRIX; GELATIN SPONGE; HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; FEMALE; HEMORRHAGIC SHOCK; HEMOSTASIS; HEPARINIZATION; LIVER RUPTURE; MALE; NONHUMAN; PRIORITY JOURNAL; SPLEEN RUPTURE; SWINE; ANIMAL; DISEASE MODEL; EVALUATION; INJURY; LIVER; LIVER DISEASE; METABOLISM; RUPTURE;

ANIMALS; BLOOD COAGULATION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GELATIN SPONGE, ABSORBABLE; HEMOGLOBINS; HEMOSTATICS; LIVER; LIVER DISEASES; MALE; RUPTURE; SHOCK, HEMORRHAGIC; SPLENIC RUPTURE; SUS SCROFA; THROMBIN;

EID: 43149124002     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3180340de1     Document Type: Article

References (28)

1. Hoyt DB, Bulger EM, Knudson MM, et al. Death in the operating room: an analysis of a multi-center experience. J Trauma. 1994; 37:426-432.
2. Shapiro MB, Jenkins DH, Schwab CW, et al. Damage control: collective review. J Trauma. 2000;49:969-978.
3. Haan JM, Bochicchio GV, Kramer N, et al. Nonoperative management of blunt splenic injury: a 5-year experience. J Trauma. 2005;58:492-498.
4. Hagiwara A, Murata A, Matsuda T, et al. The usefulness of transcatheter arterial embolization for patients with blunt polytrauma showing transient response to fluid resuscitation. J Trauma. 2004; 57:271-276.
5. Pryor JP, Braslow B, Reilly PM, et al. The evolving role of interventional radiology in trauma care. J Trauma. 2005;59:102-104.
6. Hagiwara A, Murata A, Matsuda T, et al. The efficacy and limitations of transarterial embolization for severe hepatic injury. J Trauma. 2002;52:1091-1096.
7. Hirshberg A, Wall MJ Jr, Ramchandani MK, et al. Reoperation for bleeding in trauma. Arch Surg. 1993;128:1163-1167.
8. Chan MW, Schwaitzberg SD, Demcheva M, et al. Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage. J Trauma. 2000;48:454-457.
9. Holcomb JB, Pusateri AE, Harris RA, et al. Dry fibrin sealant dressings reduce blood loss, resuscitation volume, and improve survival in hypothermic coagulopathic swine with grade V liver injuries. J Trauma. 1999;47:233-240.
10. Holcomb JB, McClain JM, Pusateri AE, et al. Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats. J Trauma. 2000;49:246-250.
11. Pusateri AE, Modrow HE, Harris RA, et al. Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine. J Trauma. 2003;55:518-526.
12. Wright JK, Kalns J, Wolf EA, et al. Thermal injury resulting from application of a granular mineral hemostatic agent. J Trauma. 2004; 57:224-230.
13. Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg. 2003;18:486-493.
14. Moore EE, Cogbill TH, Jurkovich GJ, et al. Organ injury scaling: spleen and liver (1994 revision). J Trauma. 1995;38:323-324.
15. Pachter HL, Knudson MM, Esrig B, et al. Status of nonoperative management of blunt hepatic injuries in 1995: a multicenter experience with 404 patients. J Trauma. 1996;40:31-38.
16. Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69:1376-1382.
17. Rodgers GM, Greenberg CS. Inherited coagulation disorders. In: Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematoglogy. Baltimore: Lippincott Williams & Wilkins; 1999:1701-1703.
18. Reuthebuch O, Moehrlen U, Kurrer MO, et al. Biocompatibility and biodegradation of high doses of FloSeal in rats. J Appl Res Clin Exp Therapeut (serial online). 2002;2.
19. Miyamoto K, Masuda K, Inoue N, et al. Anti-adhesion properties of a thrombin-based hemostatic gelatin in a canine laminectomy model: a biomechanical, biochemical, and histologic study. Spine. 2006; 31:E91-E97.
20. Reuthebuch O, Lachat ML, Vogt P, et al. FloSeal: a new hemostyptic agent in peripheral vascular surgery. Vasa. 2000; 29:204-206.
21. Ellegala DB, Maartens NF, Laws ER Jr. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery. 2002;51:513-515.
22. Weaver FA, Hood DB, Zatina M, et al. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16:286-293.
23. Gill IS, Ramani AP, Spaliviero M, et al. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. Urology. 2005;65:463-466.
24. Renkens JK Jr, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine. 2001;26:1645-1650.
25. Hick EJ, Morey AF, Harris RA, et al. Gelatin matrix treatment of complex renal injuries in a porcine model. J Urol. 2005;173: 1801-1804.
26. Pursifull NF, Morris MS, Harris RA, et al. Damage Control Management of Experimental Grade 5 Renal Injuries: Further Evaluation of FloSeal Gelatin Matrix. J Trauma. 2006;60:346-350.
27. L'Esperance JO, Sung JC, Marguet CG, et al. Controlled survival study of the effects of Tisseel or a combination of FloSeal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. J Endourol. 2005; 19:1114-1121.
28. Klemcke HG. Evaluation of FloSeal as a potential intracavitary hemostatic agent. J Trauma. 2006;60:385-389.